相关实验视频

Updated: Jul 28, 2025

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

Published on: December 5, 2017

一个新的范式来分类和治疗HER2阳性乳腺癌

Xuexin He¹, Sai-Ching J Yeung², Francisco J Esteva³

¹Department of Medical Oncology, Huashan Hospital of Fudan University, Shanghai, China.

Cancer reports (Hoboken, N.J.)

|May 31, 2023

概括

人类表皮生长因子受体2-阳性乳腺癌 (HER2+BC) 现在是高度可治的. 提出了一个新的分类系统来指导治疗,超越传统的分期以获得更好的患者结果.

科学领域:

在瘤学瘤学.
翻译医学是一种翻译医学.
临床研究临床研究

背景情况:

单克隆抗体和抗体-药物合物已经彻底改变了HER2阳性乳腺癌 (HER2+BC) 治疗.
在HER2+BC中,高治愈率和改善的生存率降低了TNM分期系统的预后价值.
由于HER2+BC的治愈性,因此需要改变治疗模式,而不是对反应较弱的癌症使用治疗模式.

研究的目的:

提出HER2+BC的新分类系统,包括治疗结果和毒性.
根据其改善的治愈能力,重新评估HER2+BC的分类和治疗策略.
开发一个框架,帮助临床医生优化HER2+BC患者的初始治疗方案.

主要方法:

文献审查和研究结果的分析.
在HER2+BC管理中纳入临床经验.
基于TNM分期,治疗反应和疾病程度的新型分类系统的开发.

主要成果:

一个新的分类将HER2+BC患者分为四组:可治愈,尽最大努力治愈,希望治愈,和不可治愈.
"可治愈"组包括淋巴结阴性,小 (≤3厘米) 早期乳腺癌.
该分类考虑了局部晚期的疾病,复发,有限的转移和治疗反应.

结论:

拟议的分类有助于临床医生在为HER2+BC选择最佳的初始治疗策略.
实施这种系统可以提高HER2+BC患者的治愈率和改善生活质量.
量身定制的分类和治疗方法对于管理高度可治疗的HER2+BC至关重要.

关键词:

HER2阳性乳腺癌是什么意思这是分类分类的分类.治疗治疗治疗治疗一个范式的范式.治疗治疗治疗治疗治疗治疗

更多相关视频

Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells

Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells

Published on: May 9, 2025

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Published on: April 26, 2024

相关概念视频

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...